Brokerages Set Regulus Therapeutics Inc. (NASDAQ:RGLS) Target Price at $10.80
Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price […]
Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price […]
